Additional studies demonstrated that Olig2 deletion reduces tumor growth and drives a phenotypic shift from oligodendroglial to astrocytic features, concomitant with PDGFRA downregulation and compensatory EGFR signaling pathway activation, revealing alternative routes for tumor recurrence [20]. Here, OLIG2 is linked to neoplasm.